It is an honour and privilege to be named to the Tour21 team. In June/July 2024, one week ahead of the professionals, I will be cycling the entire Tour de France route with 24 amateur cyclists, to raise funds for Cure Leukaemia. Starting in Tuscany and finishing in Nice, the Tour21 will take place from June 22 - July 14. We will be riding all 21 stages and 3,500km of the Tour de France route - one of the world's most gruelling sporting challenges.

I am seeking your generous support. My challenge is to raise $40,000 for the vital work that Cure Leukaemia do daily. All funds raised from this event are invested directly into the national Trials Acceleration Programme (TAP) network of centres that Cure Leukaemia funds. (All of the cyclists taking part in this event are self-funding their participation in it.) Your generosity means we can help transform the prospects and lives of thousands of blood cancer patients. Please consider a personal donation or through your business or company. Corporate sponsorship of the team clothing and team bus can also be arranged.

With one person diagnosed with blood cancer every 14 minutes, your support will go towards offering hope in saving more lives and eradicating leukaemia. I appreciate any support you can offer by making a donation today.

Cheers,

John Vigna

THERE ARE 3 OPTIONS TO MAKE A DONATION:

1) For Canadian-based donors, if you would like to make a tax-deductible donation personally or through your business, you can do so via this link (choose "Cure Leukemia" in the drop-down menu):

https://www.canadahelps.org/en/dn/m/30925

2) For Canadian-based donors who would like to make a tax-deductible donation personally or through your business through: wire or bank transfer, credit/debit card, cheque, stock transfers or mutual funds, email me at jvigna@gmail.com so I can send you the appropriate form.

3) For Canadian-based and non-Canadian-based donors who would like to make a non-tax-deductible donation personally or through your business, just click the "Give Now" button on the upper right side of this page.